BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Loading...
Loading...

Genaera March 2001 Magainin Pharmaceuticals Pages on BioPortfolio:

BioPortfolio - Genaera
We changed our name to Genaera Corporation on March 9, 2001. ... page: genaera. com | Genaera March 2001 Magainin Pharmaceuticals | HPH 12 | Genaera Pharma ...
http://www.bioportfolio.com/biocorporate/4330-Genaera.html...

BioPortfolio - Genaera - Profile
Delaware in 1987 as Magainin Pharmaceuticals, Inc. and began operations in 1988. We changed our name. to Genaera Corporation on March 9, 2001. Genaera ...
http://www.bioportfolio.com/biocorporate/4330-Genaera.pdf...

BioPortfolio - HPH 12
Recent Search Terms used to find this page: genaera.com | Genaera March 2001 Magainin Pharmaceuticals | HPH 12 | Genaera Pharma | genaera usa | Squalamine
...
http://www.bioportfolio.com/search/HPH_12.html...

Results from other life science and pharmaceutical sites:

BioPortfolio - Genaera
We changed our name to Genaera Corporation on March 9, 2001. ... page: genaera. com | Genaera March 2001 Magainin Pharmaceuticals | HPH 12 | Genaera Pharma ...
http://www.bioportfolio.com/biocorporate/4330-Genaera.html...

Talniflumate Genaera Darryl Knight
In September 2001, Genaera was awarded US $1.7 million from the Cystic Fibrosis Foundation to ... Magainin Pharmaceuticals Inc PRESS RELEASE 2001 March 07 ...
http://www.biomedcentral.com/content/pdf/cd-537183.pdf...

BioPortfolio - Genaera - Profile
Delaware in 1987 as Magainin Pharmaceuticals, Inc. and began operations in 1988. We changed our name. to Genaera Corporation on March 9, 2001. Genaera ...
http://www.bioportfolio.com/biocorporate/4330-Genaera.pdf...

When products fail - Nature Biotechnology
In the United States, Magainin Pharmaceuticals (Philadelphia, PA) changed its name to Genaera in March 2001 after repeated development setbacks of ...
http://www.nature.com/nbt/journal/v19/n6s/full/nbt0601supp_B...

Sheet1
48, Magainin, 10074000, 12657000, Called Genaera as of March 2001. 49, Maxygen Inc. 38534000, 99379000. 50, Millenium Pharmaceuticals, 268740000, 318055000 ...
http://www.stanford.edu/class/siw198q/websites/genomics/R&D2...

Drug treatment for chronic obstructive pulmonary disease Peter Wark
Genaera Corp: Genaera announces first clinical trial of. mucoregulator therapy. Press Release (2001) August 16. 47. Magainin Pharmaceuticals Inc: Magainin ...
http://www.biomedcentral.com/content/pdf/cd-504018.pdf...

Secondary Structure and Lipid Contact of a Peptide Antibiotic in ...
Peptides were synthesized by Genaera Pharmaceuticals (Plymouth Meeting, ..... These results are consistent with the finding that both magainin 2 and PGLa, ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=13...

Society for General Microbiology - 148th Ordinary Meeting ...
26-30 March 2001, Edinburgh, UK. Jonathan W McMichael. 1. & Jean-Michel Sallenave ... University, UK), such as magainin-2 and ranalexin. (Genaera). ...
http://www.biomedcentral.com/content/pdf/cd-412385.pdf...

Structure of (KIAGKIA)3 Aggregates in Phospholipid Bilayers by ...
Labeled peptides were synthesized by Genaera Pharmaceuticals (Plymouth ...... Mechanism of magainin 2a induced permeabilization of phospholipid vesicles. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=13...

Deal Highlights
rights to Genaera Corp's antibacterial peptide pexiganan, .... lidocaine project , to AlgoRx Pharmaceuticals Inc in March ...
http://www.biomedcentral.com/content/pdf/cd-854598.pdf...

Google Custom Search

Search
  

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.